Detalles de la búsqueda
1.
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.
Lancet Oncol
; 23(5): 671-681, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427469
2.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051385
3.
Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.
Prostate
; 77(1): 114-120, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27800640
4.
Effectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancy.
Rep Pract Oncol Radiother
; 22(1): 58-63, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27843413
5.
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
Rep Pract Oncol Radiother
; 21(1): 90-2, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26900365
6.
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 16(3): 320-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25702876
7.
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
Rep Pract Oncol Radiother
; 20(4): 259-72, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109913
8.
Role of immunotherapy in castration-resistant prostate cancer (CRPC).
BJU Int
; 113(3): 367-75, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23650874
9.
Case report: Exceptional and durable response to Radium-223 and suspension of androgen deprivation therapy in a metastatic castration-resistant prostate cancer patient.
Front Oncol
; 14: 1331643, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38525428
10.
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer.
Clin Genitourin Cancer
; 21(6): e485-e494, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453915
11.
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
Clin Transl Oncol
; 25(4): 1017-1023, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436177
12.
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
J Clin Oncol
; 41(4): 881-892, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269935
13.
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
J Clin Oncol
; 41(32): 5005-5014, 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639648
14.
Bone health and therapeutic agents in advanced prostate cancer.
Front Biosci (Landmark Ed)
; 27(1): 34, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090339
15.
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer.
Front Oncol
; 12: 891886, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35912190
16.
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.
JAMA Oncol
; 8(3): e216871, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050303
17.
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.
Eur Urol
; 82(1): 106-114, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35469702
18.
PARP inhibitors in advanced prostate cancer: when to use them?
Endocr Relat Cancer
; 28(8): T79-T93, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256353
19.
Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.
Radiother Oncol
; 160: 115-119, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964325
20.
The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
Cancer Treat Rev
; 86: 102000, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32203842